Senseonics (NYSE:SENS) Rating Increased to Strong-Buy at Mizuho

Senseonics (NYSE:SENS - Get Free Report) was upgraded by investment analysts at Mizuho to a "strong-buy" rating in a research report issued on Wednesday,Zacks.com reports.

Several other analysts also recently weighed in on the company. HC Wainwright restated a "buy" rating and issued a $2.00 price objective on shares of Senseonics in a report on Wednesday, March 5th. StockNews.com started coverage on shares of Senseonics in a report on Thursday, December 26th. They issued a "sell" rating for the company.

Senseonics Trading Up 2.9 %

Shares of NYSE SENS traded up $0.02 during mid-day trading on Wednesday, reaching $0.62. The company had a trading volume of 2,188,601 shares, compared to its average volume of 6,296,236. Senseonics has a 52 week low of $0.25 and a 52 week high of $1.40. The business's 50-day moving average is $0.78 and its 200-day moving average is $0.58. The stock has a market cap of $401.48 million, a price-to-earnings ratio of -4.74 and a beta of 0.84. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17.

Senseonics (NYSE:SENS - Get Free Report) last issued its earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.09). Senseonics had a negative return on equity of 842.25% and a negative net margin of 362.30%. During the same quarter in the previous year, the business earned ($0.07) EPS. Equities analysts expect that Senseonics will post -0.14 earnings per share for the current year.

Remove Ads

Hedge Funds Weigh In On Senseonics

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Two Sigma Investments LP purchased a new stake in shares of Senseonics during the fourth quarter valued at about $36,000. Millennium Management LLC boosted its stake in Senseonics by 299.0% in the fourth quarter. Millennium Management LLC now owns 1,088,029 shares of the company's stock valued at $569,000 after acquiring an additional 815,332 shares in the last quarter. Jane Street Group LLC grew its holdings in Senseonics by 6,694.1% in the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company's stock worth $3,203,000 after purchasing an additional 6,028,726 shares during the last quarter. First Light Asset Management LLC acquired a new position in shares of Senseonics during the fourth quarter worth $3,366,000. Finally, Northern Trust Corp lifted its holdings in shares of Senseonics by 11.2% during the 4th quarter. Northern Trust Corp now owns 1,194,960 shares of the company's stock valued at $625,000 after purchasing an additional 120,441 shares during the last quarter. Hedge funds and other institutional investors own 12.36% of the company's stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.